Acid stable trypsin i~~bit~r in bile

Acid stable trypsin inhibitor having the same antigenicity as urinary trypsin inhibitor was first identified in the bile of patients with rn~i~~t tumors (biliary tract carcinoma or pancreas head carcinoma) and gallstones. Bile trypsin inhibitor from malignant tumor patients was partially purified by DEAE cellulose ion exchange column chromatography. Two molecular forms of the inhibitor were identified. The main form had a molecular weight of about 86000 and the minor one a molecular weight of 31000 as determined by gel filtration. Using isoelectric focussing, the larger molecular form gave a pZ value of 2.0 and the smaller form, a pZ value of 5.1. The isolated larger form migrated on the slightiy cationic side of human serum albumin by analytical poiya~~la~de gel electrophoresis. The larger form reacted and fused with anti-urinary trypsin inhibitor serum and strongly inhibited trypsin, partially inhibited chymotrypsin and plasmin, but did not inhibit urokinase. The clinical significance of acid stable%ypsin inhibitor is discussed.

[1]  H. Ezaki,et al.  Isolation of urinary trypsin inhibitor-like inhibitor from human lung cancer tissue. , 1984, Cancer research.

[2]  Maruyama Masugi,et al.  Marked increase of plasma acid stable/soluble trypsin inhibitor in hemodialysis patients , 1984 .

[3]  Maruyama Masugi,et al.  Acid stable protease inhibitor in ascites of ovarian carcinoma , 1983 .

[4]  S. Moriyama,et al.  Purification and partial characterization of two forms of urinary trypsin inhibitor. , 1982, Biochimica et biophysica acta.

[5]  M. Maruyama,et al.  Low Molecular Weight Trypsin-Plasmin Inhibitors Isolated from Papain Treated Urinary Trypsin Inhibitor , 1982, Thrombosis and Haemostasis.

[6]  M. Maruyama,et al.  Human urinary trypsin inhibitors purified by affinity chromatography on trypsin-sepharose. , 1981, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society.

[7]  M. Hayashi,et al.  Further purification and some properties of human urinary trypsin inhibitor. , 1980, Investigative urology.

[8]  A. Hayem,et al.  Purification et caracterisation des inhibiteurs de proteases de l'urine humaine , 1979 .

[9]  Y. Takada,et al.  Studies on human urinary trypsin inhibitor. 1. Its modification on treatment of urine with acid. , 1977, Thrombosis research.

[10]  Smith Jm,et al.  Serum levels of a component reacting with antiserum to urinary antitrypsin in health and disease with emphasis on high levels in renal failure. , 1976 .

[11]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[12]  P. Bernabe,et al.  Characterization of the NH 2 -terminal glutamic acid and NH 2 -terminal lysine forms of human plasminogen isolated by affinity chromatography and isoelectric focusing methods. , 1973, The Journal of biological chemistry.

[13]  C. D. Nordschow,et al.  Interrelation of the urinary trypsin inhibitor to human plasma inter-alpha-trypsin inhibitor. , 1973, Clinical biochemistry.

[14]  H. Faarvang.  DOSE-RESPONSE BETWEEN EXOGENOUS CORTISONE ACETATE AND THE URINARY EXCRETION OF TRYPSIN INHIBITOR IN MAN. , 1963, Acta endocrinologica.

[15]  A. Mayehiro.  Studies of trypsin inhibitor in urine.Report 4. , 1960 .

[16]  H. Faarvang,et al.  Relation between Pituitary-Adrenal System and Excretion of Trypsin Inhibitor in Urine.∗ , 1958, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[17]  E. Kawashita,et al.  Purification and some properties of a plasma protein which reacts with an antiserum against urinary trypsin inhibitor-1. , 1983, Scandinavian journal of clinical and laboratory investigation.

[18]  赤澤 憲治.  Acid stable protease inhibitor in ascites of ovarian carcinoma , 1983 .

[19]  H. Sumi,et al.  Urinary trypsin inhibitor and urokinase activities in renal diseases. , 1982, Acta haematologica.

[20]  H. Sumi,et al.  Immunochemical studies of human urinary trypsin inhibitor. , 1981, Enzyme.

[21]  R. Freeman,et al.  Serum levels of a component reacting with antiserum to urinary antitrypsin in health and disease with emphasis on high levels in renal failure. , 1976, The Journal of laboratory and clinical medicine.

[22]  E. Pettersson,et al.  Isoelectric fractionation, analysis, and characterization of ampholytes in natural pH gradients. VII. The isoelectric spectra of fungal laccase A and B. , 1968, Acta chemica Scandinavica.

[23]  C. Djerassi,et al.  Isoelectric fractionation, analysis, and characterization of ampholytes in natural pH gradients. IV. Further studies on the resolving power in connection with separation of myoglobins. , 1966, Acta chemica Scandinavica.

[24]  O OUCHTERLONY,et al.  Diffusion-in-gel methods for immunological analysis. , 1958, Progress in allergy.